Subclinical Acute Kidney Injury Is Acute Kidney Injury and Should Not Be Ignored

Jay L Koyner,Jay L. Koyner
DOI: https://doi.org/10.1164/rccm.202006-2239ED
IF: 24.7
2020-09-16
American Journal of Respiratory and Critical Care Medicine
Abstract:Serum creatinine (SCr) has long been known to be an imperfect biomarker of kidney function ( 1 ). Although consensus definitions of acute kidney injury (AKI) using SCr exist, they remain limited ( 2 ). More specifically, owing to the nature of renal reserve, it often takes a significant amount of (tubular) injury to translate into a rise in SCr concentrations from baseline ( 3 ). Over the last decade, countless investigations have sought to discover and validate biomarkers of AKI that can identify patients who have early kidney injury ( 4 ). This concept of elevation in kidney injury biomarkers in the absence of changes in traditional markers (SCr and urine output [UO]) has been dubbed "subclinical AKI" ( 5 ). However, given the mounting evidence and multiple methods of detecting this injury, perhaps it needs a different name because it will not be subclinical for much longer. It is with this backdrop that, in this issue of the Journal , Dépret and colleagues (pp. 822–829 ) investigated plasma proenkephalin A (penKid), a 5-kD stable breakdown product of enkephalins that accumulates in the setting of reduced glomerular filtration (GFR) as a biomarker of subclinical AKI in critically ill patients ( 6 ).
respiratory system,critical care medicine
What problem does this paper attempt to address?